Abstract
Chimeric proteins are composed of a cell-targeting moiety and a cell-killing moiety. In this study, a chimeric protein, STXA1-GM-CSF, composed of catalytic domain of Shiga toxin (A1) and granulocyte-macrophage colony-stimulating factor (GM-CSF) was constructed and expressed in E. coli. Cytotoxicity, receptor blocking, and neutralization experiments revealed that the chimeric protein induced cytotoxic effect on different cell lines. This effect was found to be specific, due to the presence of the killing moiety (A1), which exerts its effect through a specific GM-CSF-targeting domain, by binding to its receptor present on those cell lines. These initial investigations indicate that the chimeric protein was functional; further analyses are required for its application.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AML:
-
acute myeloid leukemia
- (h)GM-CSF:
-
(human) granulocyte-macrophage colony-stimulating factor
- MTT:
-
3-3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyletrazolium bromide
- RIP:
-
ribosome-inactivating protein
- SDS-PAGE:
-
sodium docecyl sulfate–polyacrylamide gel electrophoresis
- SLT:
-
Shiga-like toxin
- STX:
-
Shiga toxin
References
Al-Jaufy AY, Haddad JA, King SR, McPhee RA, Jackson MP. Cytotoxicity of a Shiga toxin A subunit-CD4 fusion protein to human immunodeficiency virus-infected cells. Infect Immun. 1994;62:956–60.
Bendle AE, Shao Y, Davies SM, et al. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor. Leuk Lymphoma. 1997;25:257–70.
Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterisation of human hemopoietic stem cells. Science. 1995;267:104–8.
Budel LM, Touw IP, Delwel R, Clark SC, Lowenberg B. Interlekin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood. 1989;74:565–71.
Chiba S, Shibuya K, Piao Y, et al. Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. Cell Regul. 1990;1:327–35.
Frankel AE, Hall PD, Burbage C, et al. Modulation of the apoptotic response of human myeloid leukemia cells of a diphtheria toxin granulocyte-macrophage colony-stimulating factor fusion protein. Blood. 1997;90:3654–61.
Frankel AE, Powell BL, Hall PD, Case LD, Kreitman JR. Phase I trial of a novel diphtheria toxin/GMCSF fusion protein (DT388GCSF) for refractory or relapsed acute myeloid leukaemia (AML). Clin Cancer Res. 2002a;8:1004–13.
Frankel AE. Receptor upregulation enhances cell surface receptor targeted therapies. Leuk Res. 2002b;26:1069–71.
Habibi Roudkenar M, Bouzari S, Oloomi M, Jafari A, Shahrokhi N, Shokrgozar MA. Expression of a chimeric protein containing the catalytic domain of Shiga-like toxin and human granulocyte-macrophage colony-stimulating factor (hGM-CSF) in Escherichia coli and its recognition by reciprocal antibodies. Iranian Biomed J. 2005;9:143–8.
Kojio S, Zhang HM, Ohumara M, Gondaira F, Kobayashi N, Yamamoto T. Caspase-3 inactivation and apoptosis induction coupled with the retrograde transport of Shiga toxin: inhibition by brefeldin A. FEMS Immunol Med Microbiol. 2000;29;275–81.
Lyne PD, Bamborough TL, Duncan D, Richards WG. Molecular modelling of the GM-CSF and IL-3 receptor complexes. Protein Sci. 1995;4:2223–33.
Narayanan S, Suredranath K, Bora N, Surolia A, Karande AA. Ribosome inactivating protein and apoptosis. FEBS Lett. 2005;579:1324–31.
Sakamaki K, Miyajima I, Kitamura T, Miyajima A. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosporylation. EMBO J. 1992;11:3541–9.
Skinner LM, Jackson MP. Inhibition of prokaryotic translation by the Shiga toxin enzymatic subunit. Microb Pathog. 1998;24:117–22.
Stirpe F. Ribosome-inactivating proteins. Toxicon. 2004;44:371–83.
Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin 2. J Immunol Methods. 1986;9:157–65.
Terpstra W, Rozemuller H, Breems DA, et al. Diphtheria toxin fused to granulocyte-macrophage stimulating-factor eliminates acute myeloid leukaemia cells with the potential to initiate leukaemia in immunodeficient mice, but spares normal hemopoietic stem cells. Blood. 1997;90:3735–42.
Williams MD, Rostovtsev A, Narla RK, Uckun FM. Production of recombinant DTct GMSF in a Baculovirus expression vector system for biotherapy of GMCSF-receptor sensitive hematologic malignancies. Protein Expr Purif. 1998;13:210–21.
Wognum AW, Westerman Y, Visser TP, Wagemaker G. Distribution of receptors for granulocyte-macrophage colony-simulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets. Blood. 1994;84:764–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roudkenar, M.H., Jafari, A., Oloomi, M. et al. Selective cytotoxicity of recombinant STXA1-GM-CSF protein in hematopoetic cancer cells. Cell Biol Toxicol 22, 213–219 (2006). https://doi.org/10.1007/s10565-006-0051-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10565-006-0051-y